FredJKudrikMD

PubMed

• 8 citations
  Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC).
  John D. Hainsworth, David M. Waterhouse, Kent C. Shih, Ralph V. Boccia, Victor M. Priego, Michael McCleod, Fred J. Kudrik, Reed Brian Mitchell, Howard A. Burris, F. An...> ;Lung Cancer. 2018 Apr 1
• 17 citations
  TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer
  Denise A. Yardley, Edward Arrowsmith, Brooke R. Daniel, Janice F. Eakle, Adam Brufsky, David Drosick, Fred J. Kudrik, Linda D. Bosserman, Mark Keaton, Sharon A. Goble,...> ;Breast Cancer Research and Treatment. 2017 May 15
• 101 citations
  A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adeno...
  Al B. Benson, Zev A. Wainberg, J. Randolph Hecht, Dmitry Vyushkov, Hua Dong, Johanna C. Bendell, Fred Kudrik> ;The Oncologist. 2017 Mar 1
• 54 citations
  Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Pat...
  Mark A. Socinski, Frederic J. Kaye, David R. Spigel, Fred J. Kudrik, Santiago Ponce, Peter M. Ellis, Margarita Majem, Paul Lorigan, Leena Gandhi, Martin Gutierrez, Dal...> ;Clinical Lung Cancer. 2017 Jan 1
• 40 citations
  A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States.
  Lawrence E. Flaherty, Omid Hamid, Gerald P. Linette, Lynn M. Schuchter, Sigrun Hallmeyer, Rene Gonzalez, C. Lance Cowey, Anna C. Pavlick, Fred J. Kudrik, Brendan D. Cu...> ;Cancer Journal. 2014 Jan 1
• 9 citations
  The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA).
  John F. Reitan, Fred J. Kudrik, Kayleen Fox, Arletta van Breda, Sanatan Shreay, Patricia K. Corey-Lisle> ;Journal of Medical Economics. 2013 Feb 21
• 4 citations
  Phase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer.
  Rachel Borson, Graydon Harker, James Reeves, Thaddeus Beck, Steven Hager, William Horvath, Michael Jones, Guy Tillinghast, Edward Arrowsmith, Grant Harrer, Fred J. Kud...> ;Clinical Breast Cancer. 2012 Oct 1
• 252 citations
  Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies
  Robert Z. Orlowski, Peter M. Voorhees, Reynaldo Garcia, Melissa D. Hall, Fred J. Kudrik, Tammy Allred, Anandhi R. Johri, Paul Jones, Anastasia Ivanova, Hendrik W. van ...> ;Blood. 2005 Apr 15
• 9 citations
  Catastrophic antiphospholipid antibody syndrome
  Stephan Moll, Fred J. Kudrik, David B. Thomas> ;American Journal of Hematology. 2003 Apr 1
• 16 citations
  Hypersensitivity pneumonitis in advanced non-small-cell lung cancer patients receiving gemcitabine and paclitaxel: report of two cases and a review of the literature.
  Fred J. Kudrik, M. Patricia Rivera, Paul L. Molina, Susan J. Maygarden, Mark A. Socinski> ;Clinical Lung Cancer. 2002 Jul 1
• Join now to see all